Functional Characterization Experiment summary for ENCSR501FEU
doi:10.17989/ENCSR501FEU
Summary
- Status
- released
- Assay
- CRISPR screen (Control CRISPR screen)
- Control type
- control
- Biosample summary
- Homo sapiens K562 genetically modified (insertion) using transduction
- Biosample Type
- cell line
- Tiling modality
- sparse peak
- Replication type
- isogenic
- Description
- CRISPR-dCas9-based epigenomic regulatory element screening (CERES) technology to screen a subset of putative non-coding regulatory elements identified in human K562 leukemia cells from whole genome discovery screen (validation). This validation screen was performed in K562 leukemia cells
- Nucleic acid type
- DNA
- Platform
- Illumina NovaSeq 6000
- Elements references
Attribution
ENCODE4 project
- Lab
- Tim Reddy, Duke
- Award
- UM1HG009428 (Tim Reddy, Duke)
- Project
- ENCODE
- References
- Aliases
- charles-gersbach:encode4-ceres-wt-validation-screen-k562
- Date submitted
- August 31, 2021
- Date released
- October 20, 2022
- Functional Characterization Series
- ENCSR274OEB
- Submitter comment
- Wild type
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Library |
---|---|---|---|---|---|
3 | 1 | Homo sapiens K562 cell line genetically modified (insertion) using transduction | ENCBS105LLM | ENCGM809XEK | ENCLB675LBI |
4 | 1 | Homo sapiens K562 cell line genetically modified (insertion) using transduction | ENCBS301PKY | ENCGM809XEK | ENCLB339TRC |
2 | 1 | Homo sapiens K562 cell line genetically modified (insertion) using transduction | ENCBS974GZB | ENCGM809XEK | ENCLB076DDH |
1 | 1 | Homo sapiens K562 cell line genetically modified (insertion) using transduction | ENCBS152SVK | ENCGM809XEK | ENCLB296LMO |